🚀 VC round data is live in beta, check it out!
EZZ Life Science Valuation Multiples
Discover revenue and EBITDA valuation multiples for EZZ Life Science and similar public comparables like Comvita, Culti Milano, Jacques Bogart, electroCore and more.
EZZ Life Science Overview
About EZZ Life Science
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
Founded
2015
HQ
Employees
N/A
Website
Financials (LTM)
EV
$42M
EZZ Life Science Financials
EZZ Life Science reported last 12-month revenue of $44M.
In the same LTM period, EZZ Life Science generated $4M in net income.
Revenue (LTM)
EZZ Life Science P&L
In the most recent fiscal year, EZZ Life Science reported revenue of $47M and EBITDA of $8M.
EZZ Life Science expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $44M | XXX | $47M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $35M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 74% | XXX | XXX | XXX |
| EBITDA | — | XXX | $8M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $4M | XXX | $5M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
EZZ Life Science Stock Performance
EZZ Life Science has current market cap of $57M, and enterprise value of $42M.
Market Cap Evolution
EZZ Life Science's stock price is $1.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $42M | $57M | 0.0% | XXX | XXX | XXX | $0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEZZ Life Science Valuation Multiples
EZZ Life Science trades at 1.0x EV/Revenue multiple, and 5.4x EV/EBITDA.
EV / Revenue (LTM)
EZZ Life Science Financial Valuation Multiples
As of March 23, 2026, EZZ Life Science has market cap of $57M and EV of $42M.
Equity research analysts estimate EZZ Life Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
EZZ Life Science has a P/E ratio of 12.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $57M | XXX | $57M | XXX | XXX | XXX |
| EV (current) | $42M | XXX | $42M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 5.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 6.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.2x | XXX | XXX | XXX |
| P/E | 12.8x | XXX | 12.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 14.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified EZZ Life Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
EZZ Life Science Margins & Growth Rates
EZZ Life Science's revenue in the last fiscal year grew by 0%.
EZZ Life Science Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 3% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 48% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 60% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
EZZ Life Science Public Comps
See public comps and valuation multiples for other Diagnostics & Genomics and Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Comvita | XXX | XXX | XXX | XXX | XXX | XXX |
| Culti Milano | XXX | XXX | XXX | XXX | XXX | XXX |
| Jacques Bogart | XXX | XXX | XXX | XXX | XXX | XXX |
| electroCore | XXX | XXX | XXX | XXX | XXX | XXX |
| Hain Celestial Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
EZZ Life Science M&A Activity
EZZ Life Science acquired XXX companies to date.
Last acquisition by EZZ Life Science was on XXXXXXXX, XXXXX. EZZ Life Science acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by EZZ Life Science
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEZZ Life Science Investment Activity
EZZ Life Science invested in XXX companies to date.
EZZ Life Science made its latest investment on XXXXXXXX, XXXXX. EZZ Life Science invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by EZZ Life Science
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout EZZ Life Science
| When was EZZ Life Science founded? | EZZ Life Science was founded in 2015. |
| Where is EZZ Life Science headquartered? | EZZ Life Science is headquartered in Australia. |
| Is EZZ Life Science publicly listed? | Yes, EZZ Life Science is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of EZZ Life Science? | EZZ Life Science trades under EZZ ticker. |
| When did EZZ Life Science go public? | EZZ Life Science went public in 2021. |
| Who are competitors of EZZ Life Science? | EZZ Life Science main competitors are Comvita, Culti Milano, Jacques Bogart, electroCore. |
| What is the current market cap of EZZ Life Science? | EZZ Life Science's current market cap is $57M. |
| What is the current revenue of EZZ Life Science? | EZZ Life Science's last 12 months revenue is $44M. |
| What is the current EV/Revenue multiple of EZZ Life Science? | Current revenue multiple of EZZ Life Science is 1.0x. |
| Is EZZ Life Science profitable? | Yes, EZZ Life Science is net-income-positive (as of the last 12 months). |
| What is the current net income of EZZ Life Science? | EZZ Life Science's last 12 months net income is $4M. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.